Modus Therapeutics AB
556669-2199ActiveSwedish biotech developing sevuparin for severe inflammatory diseases.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2004
- Founded
Key Decision Makers
John Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
+3 more contacts in Funnelfeedr
Description
Modus Therapeutics is a Swedish biotechnology company focused on developing novel treatments for severe medical conditions with high unmet needs. Their proprietary polysaccharide, sevuparin, is the core asset under development. Sevuparin is designed as a heparinoid that modifies inflammation while m...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556669219901
Decision Makers
7 contacts in FunnelfeedrJohn Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
Ellen Donnelly
Board Member
Claes Lindblad
CFO & Head of IR
Ellen K. Donnelly
Board Member
Similar Companies
20 similar companies in FunnelfeedrSangair AB
3 employeesDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
ZEALAND PHARMA A/S
0 employeesDeveloping peptide medicines for metabolic health challenges globally.
Disruptive Pharma AB (publ)
5–9 employeesSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Abera Bioscience AB
Developing next-generation nasal vaccines using modular OMV platform technology.
bioMérieux Sweden AB
20–49 employeesWorld leader developing in vitro diagnostics for health and safety.
Browse More
Modus Therapeutics AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo